We are excited to welcome Steve to Phathom during this important growth period for our Company,” said Michael Cola, Chairman of Phathom. “Steve is an accomplished biopharmaceutical leader with a ...
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals ... BioForm Medical and its successor Merz Aesthetics. During his tenure at BioForm Medical and later Merz Aesthetics ...
Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our outstanding results and especially our strong revenue growth. At BI Sky Global we are clearly ...
BERLIN - Germany's would-be Chancellor Friedrich Merz identified on Friday migration, economic competitiveness and spending cuts as major areas needing agreement with intended coalition partners ...
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
“America’s tech giants, financial industry, and pharma companies have deep roots ... Economic and security implications of the Merz chancellorship — Atlantic Council’s North Africa ...
Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor ...
HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a ...
ProBioGen has appointed Dr. Alfred Merz, PhD, as Chief Executive Officer (CEO), effective April 1, 2025. Dr. Merz previously ...
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year. Sign up here. Shares have dropped on worries Trump's extensive plans for ...
But now the party is set to return to its long-standing position in the opposition after a disappointing fourth-place finish in Germany’s national election, far behind Friedrich Merz’s victorious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results